CTLA4 and inflammatory bowel disease: Several investigations have reported that haploinsufficiency resulting from mutations in CTLA-4 in humans is associated with IBD, and genome-wide association studies (GWAS) have implicated CTLA-4 as a susceptibility gene for IBD (Zeissig et al., 2015; Angelino et al., 2021; Liu et al., 2015).